Question 1

Does Corient Private Wealth own BBIO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Corient Private Wealth holds 23,950 shares of BBIO (Bridgebio Pharma), worth $1.8M.

Question 2

How many shares of BBIO does Corient Private Wealth own?

Accepted Answer

As of its Q2 2026 13F, Corient Private Wealth holds 23,950 shares of BBIO (Bridgebio Pharma).

Question 3

What is Corient Private Wealth's BBIO position worth?

Accepted Answer

As of its Q2 2026 13F, Corient Private Wealth's BBIO position is worth $1.8M.

Question 4

Is Corient Private Wealth buying or selling BBIO?

Accepted Answer

In Q2 2026, Corient Private Wealth reduced its BBIO position by 329 shares (-1.4%).

Question 5

When did Corient Private Wealth first buy BBIO?

Accepted Answer

Corient Private Wealth already held BBIO in its Q4 2022 13F, the earliest on record, and has listed it in 14 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	23,950	-1.4%	$1.8M	0.0%	$74.48	0
2026-Q1	Increased	24,279	+47.7%	$1.1M	0.0%	$74.26	34
2025-Q4	Decreased	16,436	-4.7%	$1.3M	0.0%	$76.49	0
2025-Q3	Increased	17,247	+15.8%	$895,810	0.0%	$51.94	29
2025-Q2	New	14,894	—	$643,124	0.0%	$43.18	34
2025-Q1	Exited	0	-100.0%	$0	0.0%	$34.57	0
2024-Q4	Decreased	19,259	-0.5%	$967	0.0%	$27.44	0
2024-Q3	Increased	19,363	+0.6%	$492,982	0.0%	$25.46	24